Table 3.
Cardiovascular risk factor control and target organ damage at baseline
| Parameter |
Overall population N = 266 |
Renal resistive index < 0.70 N = 166 |
Renal resistive index ≥ 0.70 N = 100 |
P |
|---|---|---|---|---|
| Blood pressure data | ||||
| 24‐h systolic BP, mm Hg | 133.4 ± 16.7 | 130.9 ± 15.9 | 137.5 ± 17.4 | .002 |
| 24‐h diastolic BP, mm Hg | 76.5 ± 9.4 | 78.2 ± 8.9 | 73.7 ± 9.4 | <.001 |
| 24‐h pulse pressure, mm Hg | 56.9 ± 12.4 | 52.7 ± 10.4 | 63.8 ± 12.4 | <.001 |
| Daytime systolic BP, mm Hg | 137.1 ± 16.6 | 134.6 ± 16 | 141.1 ± 17 | .002 |
| Daytime diastolic BP, mm Hg | 79.6 ± 9.8 | 81.3 ± 9.4 | 76.6 ± 9.6 | <.001 |
| Nighttime systolic BP, mm Hg | 125.9 ± 18.2 | 123.8 ± 17.1 | 129.7 ± 19.4 | .012 |
| Nighttime diastolic BP, mm Hg | 70.5 ± 9.8 | 72.2 ± 9.4 | 67.5 ± 9.7 | <.001 |
| Biological data | ||||
| LDL cholesterol, g/L | 0.9 ± 0.3 | 1 ± 0.3 | 0.9 ± 0.3 | .094 |
| HDL cholesterol, g/L | 0.5 ± 0.2 | 0.5 ± 0.2 | 0.5 ± 0.2 | .52 |
| HbA1C, % | 8.1 ± 1.7 | 8 ± 1.6 | 8.3 ± 1.9 | .23 |
| HBA1C, mmol/mol | 65 ± 13.6 | 64 ± 12.8 | 67 ± 15.3 | .23 |
| Proteinuria, g/L | 0.1 (0; 0.1) | 0.1 (0; 0.1) | 0.1 (0; 0.2) | .63 |
| Left ventricular hypertrophy data | ||||
| Sokolow index, mm | 13 (10; 17) | 13 (10; 17) | 13 (10; 16) | .96 |
| Cornell product, mm*ms | 1080 (800; 1501) | 1073 (783; 1410) | 1113 (855; 1598) | .19 |
| r wave AVL lead, mm | 5.5 (4; 8) | 5 (3; 7) | 6 (4; 9) | .010 |
| Left ventricular mass, g/m2.7 | 38.7 ± 11 | 37.3 ± 9.7 | 41 ± 12.5 | .068 |
Continuous variables are presented using mean ± standard deviation or median (Q1; Q3) otherwise. Categorical variables are presented using N (%).